FDA Import Refusal AMN-0103137-2/232/1A — BALAXI HEALTHCARE DOMINICANA
The FDA refused shipment AMN-0103137-2/232/1A from BALAXI HEALTHCARE DOMINICANA (Dominican Republic) on May 14, 2025. The refused product falls under Drugs and Biologics — LORATADINE (ANTI-ASTHMATIC). Cited charge: 75 This firm has 2 other import refusals on record.
Refusal details
- Date
- May 14, 2025
- Country
- Dominican Republic
- Product Category
- Drugs and Biologics
- Product Code
- 61EDY08 LORATADINE (ANTI-ASTHMATIC)
- Charges
- 75